Max Probiotic By Kyo-Dophilus Overview & Drug Interactions
Check For Interactions With Max Probiotic
Supplement: Max Probiotic by Kyo-Dophilus
Max Probiotic Label Images
This product contains
Below is a list of the 'active' ingredients listed on the supplement label for this product.
For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.
Proprietary Blend
| Ingredient Group | Proprietary Blend |
|---|---|
| Category | blend |
-
Lactobacillus gasseri KS-13
Ingredient Group Lactobacillus gasseri Category bacteria
Bifidobacterium bifidum G9-1
Ingredient Group Bifidobacterium bifidum Category bacteria
Bifidobacterium longum MM-2
Ingredient Group Bifidobacterium longum Category bacteria
Lactobacillus plantarum UALp-05
Ingredient Group Lactobacillus plantarum Category bacteria
Lactobacillus paracasei UALpc-04
Ingredient Group Lactobacillus paracasei Category bacteria
Bifidobacterium lactis UABla-12
Ingredient Group Bifidobacterium animalis lactis Category bacteria
Bifidobacterium longum BB536
Ingredient Group Bifidobacterium longum Category bacteria
Lactobacillus acidophilus UALa-01
Description:Lactobacillus acidophilus is a type of lactic acid-producing bacteria that is commonly found in the human gut, as well as in other areas of the body such as the mouth and vagina. L. acidophilus can also be found in fermented foods such as yogurt and kefir. It is commonly utilized in probiotic dietary supplements as it is considered a "friendly" or "beneficial" bacteria because it helps to maintain the balance of microorganisms in the body, and is purported to help improve digestion and boost the immune system. Some studies have suggested that L. acidophilus may also have a role in preventing and treating certain conditions such as diarrhea, vaginal yeast infections, and eczema.
See More Information Regarding Lactobacillus Acidophilus
Ingredient Group Lactobacillus acidophilus Category bacteria
Bifidobacterium breve M-16V
Ingredient Group Bifidobacterium breve Category bacteria
Bifidobacterium infantis M-63
Ingredient Group Bifidobacterium infantis Category bacteria
Lactobacillus gasseri LAC-343
Ingredient Group Lactobacillus gasseri Category bacteria
Lactobacillus rhamnosus LCS-742
Ingredient Group Lactobacillus rhamnosus Category bacteria
Drugs that interact with Max Probiotic by Kyo-Dophilus
Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.
Label Information
Supplement Facts:
| Daily Value (DV) Target Group(s): | Adults and children 4 or more years of age |
|---|---|
| Minimum serving Sizes: |
1 Delayed Release Capsule(s)
|
| Maximum serving Sizes: |
1 Delayed Release Capsule(s)
|
| Servings per container | 30 |
| Ingredient | Amount per Serving | Group | % DV, Adults & children 4+ years |
|---|---|---|---|
| Proprietary Blend |
0 NP
|
Proprietary Blend |
--
|
| Lactobacillus gasseri KS-13 |
0 NP
|
Lactobacillus gasseri |
|
| Bifidobacterium bifidum G9-1 |
0 NP
|
Bifidobacterium bifidum |
|
| Bifidobacterium longum MM-2 |
0 NP
|
Bifidobacterium longum |
|
| Lactobacillus plantarum UALp-05 |
0 NP
|
Lactobacillus plantarum |
|
| Lactobacillus paracasei UALpc-04 |
0 NP
|
Lactobacillus paracasei |
|
| Bifidobacterium lactis UABla-12 |
0 NP
|
Bifidobacterium animalis lactis |
|
| Bifidobacterium longum BB536 |
0 NP
|
Bifidobacterium longum |
|
| Lactobacillus acidophilus UALa-01 |
0 NP
|
Lactobacillus acidophilus |
|
| Bifidobacterium breve M-16V |
0 NP
|
Bifidobacterium breve |
|
| Bifidobacterium infantis M-63 |
0 NP
|
Bifidobacterium infantis |
|
| Lactobacillus gasseri LAC-343 |
0 NP
|
Lactobacillus gasseri |
|
| Lactobacillus rhamnosus LCS-742 |
0 NP
|
Lactobacillus rhamnosus |
|
| Other Ingredients: |
Starch
Forms
Hypromellose
Silicon Dioxide
Calcium Phosphate
|
|---|
Label Statments:
| Formulation |
- Maximum reinforcement for gut health
- DNA sequencing verified
- Non GMO
Gluten free
Dairy free
- Free of: GMOs, soy, gluten, dairy, sodium, preservatives, artificial colors and flavors.
- The probiotic strains in this product have been identity-verified using DNA sequencing.
|
|---|---|
| Formula |
- 50 billion CFU
|
| FDA Statement of Identity |
- Probiotic Supplement
|
| Suggested/Recommended/Usage/Directions |
- Suggested use: Take one capsule daily. Not recommended for children under 12.
|
| Precautions |
- Consult your healthcare professional before using this or any product if you are pregnant, nursing or under medical care.
- Keep out of reach of children.
- Safety seal: Do not use if cap drop ring or printed inner seal is broken or missing. Glass bottle, handle with care.
|
| Storage |
- Refrigeration not required.
Store in a cool, dry place with cap tight.
|
| FDA Disclaimer Statement |
- These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
|
| Seals/Symbols |
- GMP Certified
|
| Brand IP Statement(s) |
- Trademark property of UAS Labs, Inc.
|
| General Statements |
- Probiotics for You
|
Brand Information
See all products by this brand
| Manufactured by | |
|---|---|
| Name | Wakunaga of America CO., LTD. |
| Street Address | Mission Viejo |
| State | CA |
| Country | USA |
| ZipCode | 92691 |
| Phone Number | 800.421.2998 |
| [email protected] | |
| Web Address | www.kyolic.com |
Return to the main supplement interaction checker page
Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.
DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.
© 2021 Therapeutic Research Center, LLC
Drug descriptions are provided by MedlinePlus.